| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 53-86-1 | 吲哚美辛; 1-(4-氯苯甲�；�)-5-甲氧基-2-甲基-1H-吲哚-3-乙酸 | Indometacin; 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 |
| 92-72-8 | N-(5-氯-2,4-二甲氧基苯基)-3-羥基-2-萘甲酰胺 | N-(2-Hydroxynaphthoyl)-2,4-dimethoxy-5-chloroanilide; N-(5-Chloro-2,4-dimethoxyphenyl)-3-hydroxy-2-naphthalenecarboxamide |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 |
| 4273-92-1 | 色酚AS-LC; 冰染偶合組分23; 4'-氯-2',5'-二甲氧基-N-(3-羥基-2-萘甲�；�)苯胺 | Naphthol AS-LC; C.I. 37555; C.I. Azoic Coupling Component No. 23; 4'-Chloro-3-hydroxy-2',5'-dimethoxy-2-naphthanilide |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 |
| 75491-95-1 | Benzo[a][1,3]benzodioxolo[5,6-g]quinolizinium,5,6-dihydro-3-hydroxy-2-methoxy-, chloride (9CI); 3-Hydroxy-2-methoxy-10,11-(methylenedioxy)berbiniumchloride; Thalifaurine chloride |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |
| 15401-69-1 | Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium,5,6-dihydro-9-hydroxy-10-methoxy-, chloride (1:1); Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium,5,6-dihydro-9-hydroxy-10-methoxy-, chloride (9CI); Berbinium,7,8,13,13a-tetradehydro-9-hydroxy-10-methoxy-2,3-(methylenedioxy)-, chloride(8CI); 9-Berberoline chloride; 9-Demethoxy-9-hydroxyberberinium chloride; Berberrubine chloride; Beroline chloride |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |
| 58011-68-0 | 吡唑特; 4-(2,4-二氯芐氧基)-1,3-二甲基-5-吡唑基甲苯磺酸鹽; 芐草唑; 4-(2,4-二氯苯甲�；�0-1,3-二甲基-5-吡? | Methanone,(2,4-dichlorophenyl)[1,3-dimethyl-5-[[(4-methylphenyl)sulfonyl]oxy]-1H-pyrazol-4-yl]-; A 544; H468T; Pyrazolate; Pyrazolynate; SW 751; Sanbird |  | C19H16Cl2N2O4S | 詳情 | 供應(yīng)商 |
| 25803-14-9 | 1H-Indole-1-aceticacid, 3-(4-chlorobenzoyl)-6-methoxy-2-methyl-; Indole-1-aceticacid, 3-(p-chlorobenzoyl)-6-methoxy-2-methyl- (8CI); 3-(p-Chlorobenzoyl)-6-methoxy-2-methylindole-1-aceticacid; C 1656; Clometacin; Clometacine; Clometazin; Clomethacin; Duperan; Mindolic acid; R 3959 |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |
| 7681-54-1 | 1H-Indole-3-aceticacid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, sodium salt (1:1); 1H-Indole-3-aceticacid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, sodium salt (9CI); Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-, sodium salt(8CI); Indomethacin sodium; Indomethacin sodium salt; Osmosin; Sodiumindomethacin |  | C19H16ClNO4.Na | 詳情 | 供應(yīng)商 | |
| 26159-09-1 | 2(1H)-Pyrimidinone,4-amino-5-(3,4-dichlorophenyl)-1-[3-(4-nitrophenoxy)propyl]-; Cytosine,5-(3,4-dichlorophenyl)-1-[3-(p-nitrophenoxy)propyl]- (8CI); NSC 211293 |  | C19H16Cl2N4O4 | 詳情 | 供應(yīng)商 | |
| 23572-67-0 | 2(1H)-Pyrimidinone,4-amino-5-(3,4-dichlorophenyl)-1-[3-(2-nitrophenoxy)propyl]-; Cytosine,5-(3,4-dichlorophenyl)-1-[3-(o-nitrophenoxy)propyl]- (8CI); NSC 211287 |  | C19H16Cl2N4O4 | 詳情 | 供應(yīng)商 | |
| 112970-33-9 | 3H-Oxazolo[4,3-a]isoquinolin-3-one,1-(4-chlorophenyl)-5,6-dihydro-8,9-dimethoxy-; 3H-Oxazolo[4,3-a]isoquinolin-3-one, 1-(4-chlorophenyl)-5,6-dihydro-8,9-dimethoxy- |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |
| 26250-41-9 | 2(1H)-Pyrimidinone,4-amino-5-(3,4-dichlorophenyl)-1-[3-(3-nitrophenoxy)propyl]-; Cytosine,5-(3,4-dichlorophenyl)-1-[3-(m-nitrophenoxy)propyl]- (8CI); NSC 211286 |  | C19H16Cl2N4O4 | 詳情 | 供應(yīng)商 | |
| 944261-79-4 | 2-Furancarboxamide,5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)-; A803467 |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |
| 104153-37-9 | 2(1H)-Pyridinone,6-[[4-(4-chlorophenoxy)phenoxy]methyl]-1-hydroxy-4-methyl-; Rilopirox |  | C19H16ClNO4 | 詳情 | 供應(yīng)商 | |